NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 3rd Nov 2025 NOVO-B STOCK Price closed @ 315.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 759.83 & Strong Sell for SHORT-TERM with Stoploss of 948.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 318.10 Change Price %
High 321.20 1 Day -0.65 -0.21
Low 314.80 1 Week -27.70 -8.08
Close 315.30 1 Month -67.90 -17.72
Volume 3216609 1 Year -607.70 -65.84
52 Week High 1028.00 | 52 Week Low 289.50
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
CONFRZ 0.02 0.00%
NOVO-B 315.30 -0.21%
ALMB 18.84 3.29%
VWS 133.00 0.80%
VJBA 7.11 0.14%
GREENH 0.41 -6.82%
DANSKE 290.30 0.35%
ASTRLS 1.15 8.49%
ORSTED 115.20 -0.52%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
MONSO 0.17 41.67%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SHAPE 13.32 11.37%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
ATLA-DKK 2.50 6.84%
TGAMES 13.60 5.84%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
FOM 5.04 -15.72%
FOM 5.04 -15.72%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE327.63
RESISTANCE323.68
RESISTANCE321.23
RESISTANCE318.79
SUPPORT311.81
SUPPORT309.37
SUPPORT306.92
SUPPORT302.97
 
NOVO-B Forecast November 2025
4th UP Forecast559.64
3rd UP Forecast481.28
2nd UP Forecast432.84
1st UP Forecast384.41
1st DOWN Forecast246.19
2nd DOWN Forecast197.76
3rd DOWN Forecast149.32
4th DOWN Forecast70.96
 
NOVO-B Weekly Forecast
4th UP Forecast385.06
3rd UP Forecast362.69
2nd UP Forecast348.86
1st UP Forecast335.03
1st DOWN Forecast295.57
2nd DOWN Forecast281.74
3rd DOWN Forecast267.91
4th DOWN Forecast245.54
 
NOVO-B Forecast2025
4th UP Forecast1752.07
3rd UP Forecast1291.29
2nd UP Forecast1006.47
1st UP Forecast721.65
1st DOWN Forecast-91.05
2nd DOWN Forecast-375.87
3rd DOWN Forecast-660.69
4th DOWN Forecast-1121.47
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service